Therapeutic Areas / All therapeutic areas

Your needs,
our answers

With over 55 products in 9 therapeutic areas, Alfasigma is a key player in the Italian pharmaceutical industry, boasting a portfolio ranging from prescription specialties and over-the-counter products all the way to nutraceuticals.

In Italy, it is a market leader for prescription drugs, boasting a presence in many primary care therapeutic areas (gastroenterology, vascular and diabetes, cardiology, orthopaedics and rheumatology, broncho-pneumology), as well as for well-known over-the-counter products such as Biochetase, Neo-Borocillin, Dicloreum and Yovis.

Worldwide, Alfasigma has products in the following therapeutic areas.

Gastroenterology

Gastrointestinal therapeutics are our specialty. Everyday we strive to give a concrete answer to functional gastro-intestinal disorders, gastro-oesophageal reflux disorder, hepatic encephalopathy and chronic liver disease (cirrhosis).

Vascular

Vascular investigation is a company corporate mission. Venous diseases, lower extremity artery disease, diabetic microangiopathies and ventricular arrhythmia are the main pathologies in which we offer solutions.

Metabolic

In the metabolic area, our R&D has developed Carnitine, an amino acid derivative whose insufficiency can impair the metabolism of essential tissues, such as those of the heart and muscles.

Nutraceuticals & Medical foods

With our supplements, we are responding to the demand for a vast range of elements aimed at neural tissue well-being, recovery of muscle tone and combating physical and mental fatigue.

Read More

Our Research & Development Department is focused on three main therapeutic areas: gastroenterology, vascular disease & neuroscience disorders.
We are an international pharmaceutical company. Our headquarters are based in Italy, where we are deeply rooted as one of the leading companies in primary care.
Alfasigma is a leading company in Contract Manufacturing, a unique partner in outsourcing activities for the manufacturing of nearly all pharmaceutical forms.